Maple Syrup Disease (MSUD) is an inherited metabolic disorder, that, if untreated, causes mental retardation, physical disabilities and death. It was first described as a disease in 1954. MSUD is a rare disorder and believed to be in all ethnic groups worldwide. It is said to occur in 1 out of 225,000 births in the nation.

MSUD derives its name from the sweet, burnt sugar, or maple syrup smell of the urine. The disorder affects the way the body processes certain components of protein. These components are the three branched-chain amino acids—leucine, isoleucine, and valine. These amino acids accumulate in the blood causing a toxic effect that interferes with brain functions.

TYPES & SYMPTOMS
The term Maple Syrup Urine Disease includes a range of classic and variant types of the disorder. The symptoms of classic MSUD are evident within the first week of life. Variant forms of MSUD are milder, however, the symptoms can be severe during times of illness.

The earliest symptoms of classic MSUD, usually observed in the first few days of life, are poor appetite, irritability, and the characteristic odor of the urine. Affected infants gradually lose their sucking reflex and become listless, have a high-pitched cry, and become limp with episodes of rigidity. Without diagnosis and treatment, symptoms progress to seizures, coma, and death usually by two weeks of age. The earlier these infants are diagnosed and treated, the less risk of permanent damage.

TESTING FOR MSUD
Some states test for MSUD in their newborn screening programs. MSUD should be included in all screening programs. Ideally each infant should be tested within 24 hours of birth and the test results available by two to three days of age. This should be the goal of all testing for MSUD. Early diagnosis is of paramount importance for the child with MSUD to develop normally.

Unfortunately some variant types of MSUD may be missed with screening programs. However, any child at risk or suspected of having MSUD should be tested. If the result is positive, or suspected to be positive, therapy should be started immediately.

Testing to identify carriers is only available for the Mennonite classic type of MSUD. The Mennonite population from eastern Pennsylvania is at high risk for this classic form of the disorder.

TREATMENT
Treatment of children with MSUD must be started as soon as possible, preferably at birth. It involves a complex approach of maintaining metabolic control. A special, carefully controlled diet is the focus of daily treatment. This requires careful monitoring of protein intake and close medical supervision.

The diet centers around a synthetic formula or "medical food" which provides nutrients and all the amino acids except leucine, isoleucine and valine. These three amino acids are added to the diet with carefully controlled amounts of food to provide the protein necessary for normal growth and development without exceeding the level of tolerance.

Various tests are available to monitor the levels of the amino acids and their keto acid derivatives in the blood and urine. Illnesses and stress, as well as consuming too much protein, raise these levels. Even mild illnesses can become life threatening. A metabolic imbalance requires dietary changes and at times hospitalization.

AN INHERITED DISORDER
Each parent of a child with MSUD carries a defective gene for MSUD along with a normal gene. The defective gene is a recessive gene, therefore parents are called "carriers" and are not affected by the disease. Each child receives one gene from each parent.

When both parents are carriers, there is a 1 in 4 chance with each pregnancy that the baby will receive a defective gene from each parent and have MSUD; a 2 in 4 chance the baby will receive one defective and one normal gene becoming a carrier of MSUD; and a 1 in 4 chance the baby will receive two normal genes. Persons with two normal genes cannot pass MSUD to their offspring.

MSUD FAMILY SUPPORT GROUP
It is necessary for caretakers to thoroughly understand the diet and treatment for MSUD. Parent interest in support and information prompted the first MSUD Symposium for families and professionals in 1982. It was here that the families discussed the need for a support group. In 1983 the first MSUD Newsletter was printed and distributed throughout the United States and Canada. It has continued to provide the latest information on the treatment of the disorder, reports on the latest research, up-to-date diet information, family news and related topics.

The MSUD Family Support Group is a nonprofit organization which includes families and professionals worldwide. This growing organization continues to develop resources to meet the goals of support and education. Informed families and professionals provide better care for the child with MSUD. Treatment has improved and the future continues to brighten for these children and their families.

To join the mailing list for MSUD, click here MSUD. There is a printable form to use for mailing your request. A $10.00 fee is charged to help cover the cost of publishing and mailing the MSUD NEWSLETTER. Additional donations are used to help with organizational costs, family support, and the printing of literature and information packets.

Informational Source: MSUD Family Support Group.